Impurities >> Nilotinib Impurities
+91 81692 39822 / +91 99873 02910
pharmachem@karandikars.in / info@kpharmachem.com
Impurities >> Nilotinib Impurities
Product Name | CAS Number | Molecular Structure | Molecular Formula | Molecular Weight | IUPAC Name |
---|---|---|---|---|---|
Nilotinib Impurity 1 | 641571-05-3 | C28H22F3N7O | 529.53 | 4-methyl-N-(3-(2-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide | |
Nilotinib Impurity 2 | 2119583-26-3 | C27H20F3N7O | 515.5 | N-(3-(1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide | |
Nilotinib Impurity 3 | N / A | C29H24F3N7O | 543.56 | N-(3-(2,4-dimethyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide | |
Nilotinib Impurity 4 | 641571-15-5 | C28H22F3N7O | 529.53 | 4-methyl-N-(3-(5-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide | |
Nilotinib Impurity 5 | N / A | C21H22N4O2 | 362.44 | tert-butyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate | |
Nilotinib Impurity 6 | 2119583-24-1 | C29H24F3N7O | 543.56 | N-(3-(4-ethyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide | |
Nilotinib Impurity 7 | 641571-12-2 | C12H8F3N3S | 251.21 | 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzonitrile | |
Nilotinib Impurity 8 | 917391-28-7 | C12H10F3N3O | 269.23 | 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzamide | |
Nilotinib Impurity 9 | 641571-13-3 | C12H9F3N2O2 | 270.21 | 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzoic acid | |
Nilotinib Impurity 10 | 916975-92-3 | C11H8F3N3O2 | 271.20 | 4-methyl-1-(3-nitro-5-(trifluoromethyl)phenyl)-1H-imidazole | |
Nilotinib N-oxide(Imidazole-N-oxide) Impurity 11 | N / A | C28H22F3N7O2 | 545.53 | 4-methyl-1-(3-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamido)-5-(trifluoromethyl)phenyl)-1H-imidazole 3-oxide | |
Nilotinib N-oxide(Pyrimidine-N-oxide) Impurity 12 | N / A | C28H22F3N7O2 | 545.53 | 2-((2-methyl-5-((3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)carbamoyl)phenyl)amino)-4-(pyridin-3-yl)pyrimidine 1-oxide | |
Nilotinib Impurity 12 | 851137-91-2 | C17H15N5O | 305.34 | 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide | |
Nilotinib Impurity 13 | N / A | C18H16N4O | 304.35 | 1-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)ethanone | |
Nilotinib EP Impurity 14 | 641569-94-0 | C17H14N4O2 | 306.33 | 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoic acid | |
Nilotinib Impurity 15 | 917392-54-2 | C18H16N4O2 | 320.35 | methyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate | |
Nilotinib Impurity 16 | 641569-96-2 | C11H16N4O5 | 284.27 | ethyl 4-guanidino-3-methylbenzoate nitrate | |
Nilotinib Impurity 17 | 641571-11-1 | C11H10F3N3 | 241.22 | 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline | |
Nilotinib N-Oxide(Pyridine-N-oxide) Impurity 18 | 1246817-85-5 | C28H22F3N7O2 | 545.53 | 3-(2-((2-methyl-5-((3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)carbamoyl)phenyl)amino)pyrimidin-4-yl)pyridine 1-oxide | |
Nilotinib Impurity 19 | 18595-18-1 | C9H11NO2 | 165.19 | methyl 3-amino-4-methylbenzoate | |
Nilotinib Impurity 20 | 2458-12-0 | C8H9NO2 | 151.17 | 3-amino-4-methylbenzoic acid | |
Nilotinib Impurity 21 | 1807606-80-9 | C28H22F3N7O2 | 545.53 | N-(3-(4-(hydroxymethyl)-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide | |
Nilotinib Impurity 22 | N / A | C11H10F3N3 | 241.22 | 3-(2-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline | |
Nilotinib Impurity 23 | 943320-48-7 | C10H8F3N3 | 227.19 | 3-(1H-imidazol-1-yl)-5-(trifluoromethyl)aniline | |
Nilotinib Impurity 24 | N / A | C12H12F3N3 | 255.24 | 3-(2,4-dimethyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline | |
Nilotinib Impurity 25 | 641571-16-6 | C11H10F3N3 | 241.22 | 3-(5-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline |
Disclaimer
Products under patent are offered for R&D use only. These products cannot be offered to the countries where patent law is in force. Ultimate responsibility lies wholly with the buyer of our products.